文献速递神经核医学肿瘤 PET/CT

临床与纹状体多巴胺转运体对初治帕金森病轻度行为障碍的预测因素

Clinical and Striatal Dopamine Transporter Predictors of Mild Behavioral Impairment in Drug-Naive Parkinson Disease.
PubMed 文献 · Clin Nucl Med · 2020-01-01

本研究纳入275例未用药帕金森病患者,依据神经精神量表分为伴轻度行为障碍组(89例)与不伴组(186例),并分析多巴胺转运体PET显像、认知与运动指标。结果显示32.4%患者在诊断时存在轻度行为障碍,前尾状核与前壳核多巴胺转运体可用度降低与轻度行为障碍发生相关,且伴轻度行为障碍组记忆与额叶功能更差、运动评分更高。

要点

  • 初治帕金森病患者中32.4%在诊断时即存在轻度行为障碍。
  • 前尾状核与前壳核多巴胺转运体可用度降低与轻度行为障碍发生相关。
  • 伴轻度行为障碍者记忆与额叶功能更差,运动评分更高。

核心结论

  • 早期行为障碍与纹状体前部更严重的病理受累、记忆与额叶功能障碍及运动缺陷相关,可能代表帕金森病的一种不同表型。

研究设计与样本

  • 纳入275例未用药帕金森病患者,均在6个月内完成统一帕金森病评定量表、神经心理成套测验、神经精神量表及18F-FP-CIT PET显像。
  • 依据神经精神量表将患者分为不伴轻度行为障碍组(n=186)与伴轻度行为障碍组(n=89),比较两组多巴胺转运体可用度、认知功能与运动缺陷。

主要发现

  • 诊断时32.4%的帕金森病患者存在轻度行为障碍,情感失调与动机减退是两种最常见的神经精神域。
  • 前尾状核多巴胺转运体可用度与轻度行为障碍发生相关(比值比0.60;P=0.016),前壳核亦相关(比值比0.58;P=0.008)。
  • 伴轻度行为障碍组记忆相关测验与Stroop颜色阅读测验的z评分低于不伴组。
  • 控制后壳核多巴胺转运体可用度后,伴轻度行为障碍组统一帕金森病评定量表运动评分高于不伴组(P=0.007)。

临床怎么用

  • 对初治帕金森病患者可评估轻度行为障碍,并结合纹状体前部多巴胺转运体显像与认知运动评估识别不同表型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Neuropsychiatric symptoms are important and frequent nonmotor features in Parkinson disease (PD). We explored mild behavioral impairment (MBI) in drug-naive patients with PD and its clinical and dopamine transporter (DAT) correlates. METHODS: We recruited 275 drug-naive patients with PD who had undergone Unified Parkinson's Disease Rating Scale, a neuropsychological battery, Neuropsychiatric Inventory, and N-(3-[F]fluoropropyl)-2β-carbon ethoxy-3β-(4-iodophenyl) PET within 6 months. Patients with PD were divided into groups without MBI (PD-MBI-, n = 186) and with MBI (PD-MBI+, n = 89) according to the Neuropsychiatric Inventory. We performed comparative analysis of DAT availability, cognitive function, and motor deficits between the groups. RESULTS: Mild behavioral impairment was found in 32.4% of PD patients at the time of diagnosis, and affective dysregulation and decreased motivation were the 2 most common neuropsychiatric domains. Dopamine transporter availability in the anterior caudate (odds ratio, 0.60; P = 0.016) and anterior putamen (odds ratio, 0.58; P = 0.008) was associated with the development of MBI in PD. PD-MBI+ group had a lower z-score in memory-related tests and Stroop color reading test than PD-MBI- group. PD-MBI+ group had a higher Unified Parkinson's Disease Rating Scale motor score after controlling for DAT availability in the posterior putamen than PD-MBI- group (P = 0.007). CONCLUSIONS: This study suggests that early behavioral impairment is associated with more pathological involvement in the anterior striatum, memory and frontal dysfunction, and motor deficits, which could be regarded as a different phenotype in PD.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Yoo HS, Lee S, Chung SJ, et al. Clinical and Striatal Dopamine Transporter Predictors of Mild Behavioral Impairment in Drug-Naive Parkinson Disease. Clin Nucl Med. 2020. PMID: 32956117. doi:10.1097/RLU.0000000000003281

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。